Andy Chevigné and his group, RTI-5152-twelve is postulated to boost the levels of opioid peptides that bind to classical opioid receptors in the Mind, leading to heightened painkilling action. The LIH-RTI research groups recognized a collaboration agreement and filed a joint patent software in December 2020.The opioid program during the human over